Roy F. Chemaly, MD, MPH, FIDSA, FACP
Professor of Medicine
Director, Infection Control Section
Director of Clinical Virology
Department of ID/IC/EH
UT MD Anderson Cancer Center
Houston, TX
Committee Chairman

Keith Kaye, MD, MPH
Professor of Internal Medicine
Director of Clinical Research, Division of Infectious Diseases
University of Michigan Medical School
Ann Arbor, MI

Camille Kotton, MD, FIDSA, FAST
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Massachusetts General Hospital
Harvard Medical School
Boston, MA

Expert Panel

Samuel Aitken, PharmD, BCPS-AQ ID
Clinical Pharmacy Specialist, Infectious Diseases
The University of Texas MD Anderson Cancer Center

Angela M. Caliendo, MD, PhD
Professor and Executive Vice Chair, Department of Medicine
Chief, Division of General Internal Medicine
Brown University

Daniel R. Couriel, MD, MS
Professor, Internal Medicine,
Director of Bone Marrow Transplant
University of Utah

Sanjeet Singh Dadwal, MD
Associate Clinical Professor
Head, Antimicrobial Stewardship Program
Co-Lead Infectious Disease, Transplant Disease Team
Division of Infectious Disease
Department of Medicine
City of Hope National Medical Center

Erik R. Dubberke, MD, MSPH
Associate Professor of Medicine
Director, Section of Transplant Infectious Diseases
Washington University School of Medicine

Melissa DePaoli Johnson, PharmD, MHS, AAHIVP
Associate Professor in Medicine
Division of Infectious Diseases & International Health
Duke University Medical Center

Deepali Kumar, MD, MSC, FRCPC
Associate Professor of Medicine
University of Toronto

Kerry LaPlante, PharmD, FCCP, FIDSA
Professor, College of Pharmacy
The University of Rhode Island

Michele I. Morris, MD, FACP, FIDSA, FAST
Professor of Clinical Medicine
Director, Immunocompromised Host Service
Division of Infectious Diseases
University of Miami Miller School of Medicine

Jason M. Pogue, PharmD, BCPS-AQ ID
Infectious Diseases Clinical Pharmacist
Sinai-Grace Hospital; Detroit Medical Center

Joshua Thaden, MD, PhD
Medical Instructor
Duke University

David van Duin, MD, PhD
Associate Professor of Medicine
University of North Carolina School of Medicine

Planning Committee

Susan P. Tyler, M.Ed., CHCP
Director, Continuing Medical Education
University of Cincinnati

Rick Ricer, MD
UC CME Physician Reviewer
University of Cincinnati

Caitlin Mardis, PharmD, BCPS
Director of Continuing Education & Professional Development
Clinical Assistant Professor, Clinical Pharmacy & Outcomes Sciences
University of South Carolina College of Pharmacy

Ashley Di Fiore
Context Healthcare Group

Sharon Cross, PhD
Context Healthcare Group

Disclosures Faculty

Roy Chemaly, MD
Consultant, grants/research support: Chimerix, Merck, Oxford Immunotec
Advisory Board: Astellas, The Medicines Company
Grant/research support: Novartis

Keith Kaye, MD
Consultant: Allergan, Merck, The Medicines Company
Grant/research support: Merck

Camille Kotton, MD
Consultant: Astellas, Cellestis-QIAGEN, Chimerix, Merck, Oxford Immunotec, Roche Diagnostics, Shire
Symposium Speaker: Merck, Oxford Immunotec, Roche, Roche Diagnostics, Shire
Adjudication committee member: Astellas, Merck, Shire

Disclosures Expert Panel

Samuel L. Aitken, PharmD, BCPS-AQ ID
Advisory board: Achaogen, The Medicines Company, Zavante Therapeutics
Research support: Merck, The Medicines Company
Speaker’s bureau: Merck

Angela M. Caliendo, MD, PhD
Scientific advisory board: Cepheid, DNAe, ID by DNA, Luminex, Quidel, Roche Molecular,
Research support: Hologic, T2 Biosystems

Daniel R. Couriel, MD, MS

Sanjeet Singh Dadwal, MD
Advisory board: Merck
Consultant: Merck
Research support: AiCuris, Ansun Biopharma, Gilead, GSK, Merck

Erik R. Dubberke, MD, MSPH
Research grant: Pfizer, Sanofi
Consultant: Merck, Pfizer

Melissa D. Johnson, PharmD, MHS
Grant recipient (to Duke University Medical Center): Merck

Deepali Kumar, MD, MSc, FRCPC
Clinical Trial Support (to University of Toronto): Merck, Oxford Immunotec, Qiagen, Roche, Shire
Consultant: Oxford Immunotec, Qiagen

Kerry LaPlante, PharmD, FCCP, FIDSA
Investigator-initiated research grant: Merck (April 2016-May 2018), Ocean Spray Cranberries, Inc. (January 2016-2017), Pfizer Pharmaceuticals (2016-2018)
Scientific advisor appointment (May 2017): Achaogen, Inc., Allergan, Zavante Therapeutics, Inc.
Advisor FDA for Submissions: Ocean Spray Cranberries, Inc., (December, 2016)

Michele I. Morris, MD, FACP, FIDSA, FAST
Research advisor/consultant: Chimerix
Research support: Astellas, Merck/Optimer

Jason M. Pogue, PharmD
Consultant: Merck, The Medicines Company
Research support: Merck
Speaker: Allergan, The Medicines Company

Joshua Thaden, MD, PhD

David van Duin, MD, PhD
Advisory board: Achaogen, Allergan, Astellas, Shionogi
Consultant: Neumedicines

Return to homepage